| Entry |
|
|---|
| Name |
Zanamivir (USAN/INN);
Relenza (TN)
|
|---|
| Product |
|
|---|
| Formula |
C12H20N4O7
|
|---|
| Exact mass |
332.1332
|
|---|
| Mol weight |
332.3098
|
|---|
| Structure |
     |
|---|
| Activity |
Antiviral;
Inhibitor [influenza virus neuraminidase] [DS: H00398]
|
|---|
| Remark |
|
|---|
| Comment |
Indication: Influenza A and B
|
|---|
| Target |
influenzavirus A, B neuraminidase inhibitor |
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AH Neuraminidase inhibitors
J05AH01 Zanamivir
D00902 Zanamivir (USAN/INN)
USP drug classification [BR:br08302]
Antivirals
Anti-influenza Agents
Zanamivir
D00902 Zanamivir (USAN/INN)
Antiinfectives [BR:br08307]
Antivirals
Anti-influenza agent
Uncoating inhibitor
influenzavirus A/B neuraminidase inhibitor
Zanamivir [ATC:J05AH01]
D00902 Zanamivir (USAN/INN)
 |
|---|
| Other DBs |
CAS: 139110-80-8 PubChem: DrugBank: PDB-CCD: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 23
1 C2x C 23.0207 -17.2968
2 C1y C 23.0207 -18.6980
3 C1y C 24.2381 -19.4020
4 C1y C 25.4412 -18.6980
5 O2x O 25.4412 -17.2968
6 C2y C 24.2381 -16.5997
7 N1b N 21.8098 -19.4020
8 C2c C 20.5986 -18.6980
9 N1a N 19.3875 -19.4020
10 N2a N 20.5986 -17.2968
11 C6a C 24.2397 -15.1985
12 O6a O 25.4480 -14.4960
13 O6a O 23.0261 -14.4930
14 N1b N 24.2397 -21.2232
15 C5a C 23.0261 -21.9218
16 C1a C 23.0280 -23.3230
17 C1c C 26.6469 -19.3949
18 C1c C 27.8579 -18.6909
19 C1b C 29.0690 -19.3878
20 O1a O 30.2801 -18.6838
21 O1a O 27.8548 -17.2897
22 O1a O 26.6486 -20.7961
23 O5a O 21.8111 -21.2262
BOND 23
1 11 12 1
2 5 6 1
3 11 13 2
4 6 1 2
5 3 14 1 #Down
6 14 15 1
7 2 7 1 #Up
8 15 16 1
9 7 8 1
10 4 17 1
11 1 2 1
12 17 18 1
13 8 9 1
14 18 19 1
15 2 3 1
16 19 20 1
17 8 10 2
18 18 21 1 #Down
19 3 4 1
20 17 22 1 #Up
21 6 11 1
22 15 23 2
23 4 5 1
|
|---|
